← Back
Research Paper Volume 13, Issue 6 pp 8408—8420

Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy

class="figure-viewer-img"

Figure 1. The PFS (Left) and OS (Right) of the whole cohort.